Figures & data
Figure 1. Clinical photographs. Intermediate junctional epidermolysis bullosa improved after 12 weeks of treatment with dupilumab (loading dose 600 mg s.c. with successive injections of 300 mg every other week)
Figure 2. Other clinical features of junctional epidermolysis bullosa. (a) Erythematous patches covered by vesicles and bullae localized on the friction areas of lower limbs. (b) His toenails were dystrophic. (c) The patient suffered from alopecia.
Data availability statement
The data that support the findings are available from the corresponding author, upon reasonable request.